Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis

Nature Genetics

Volumn 47, Issue 1, 2015, Pages 57-64

  Marvig, Rasmus Lykke ^a,b   Sommer, Lea Mette ^b,c   Molin, Søren ^b,c   Johansen, Helle Krogh ^a,c  

^a Rigshospitalet   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c Chalmers University of Technology   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GENOME; BACTERIAL MUTATION; BACTERIUM ISOLATE; CLONE; CONVERGENT EVOLUTION; CYSTIC FIBROSIS; EVOLUTIONARY ADAPTATION; GENE SEQUENCE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ADAPTATION; ADOLESCENT; ADULT; BACTERIAL GENE; CELL CLONE; CHILD; FEMALE; FOLLOW UP; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HETEROZYGOTE; HOST PATHOGEN INTERACTION; INFANT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MOLECULAR EVOLUTION; MOLECULAR GENETICS; MUTATION; PATHOGENICITY; PHYLOGENY; PRESCHOOL CHILD; PSEUDOMONAS INFECTION; RESPIRATORY SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SPUTUM; TRANSMISSION; VIRULENCE; YOUNG ADULT;

BACTERIAL PROTEIN;

ADAPTATION, BIOLOGICAL; ADOLESCENT; ADULT; BACTERIAL PROTEINS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; CLONE CELLS; CYSTIC FIBROSIS; EVOLUTION, MOLECULAR; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, BACTERIAL; GENE REGULATORY NETWORKS; GENES, BACTERIAL; GENOME, BACTERIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; INFANT; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY SYSTEM; SIGNAL TRANSDUCTION; SPUTUM; VIRULENCE; YOUNG ADULT;

EID: 85028139131     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3148     Document Type: Article

References (64)

1. Marvig, R.L., Johansen, H.K., Molin, S. & Jelsbak, L. Genome analysis of a transmissible lineage of Pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators. PLoS Genet. 9, e1003741 (2013).
2. Smith, E.E. et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. USA 103, 8487-8492 (2006).
3. Cramer, N. et al. Microevolution of the major common Pseudomonas aeruginosa clones C and PA14 in cystic fibrosis lungs. Environ. Microbiol. 13, 1690-1704 (2011).
4. Yang, L. et al. Evolutionary dynamics of bacteria in a human host environment. Proc. Natl. Acad. Sci. USA 108, 7481-7486 (2011).
5. Holt, K.E. et al. Tracking the establishment of local endemic populations of an emergent enteric pathogen. Proc. Natl. Acad. Sci. USA 110, 17522-17527 (2013).
6. Eyre, D.W. et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N. Engl. J. Med. 369, 1195-1205 (2013).
7. Chewapreecha, C. et al. Dense genomic sampling identifies highways of pneumococcal recombination. Nat. Genet. 46, 305-309 (2014).
8. Comas, I. et al. Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat. Genet. 45, 1176-1182 (2013).
9. Casali, N. et al. Evolution and transmission of drug-resistant tuberculosis in a Russian population. Nat. Genet. 46, 279-286 (2014).
10. Mather, A.E. et al. Distinguishable epidemics of multidrug-resistant Salmonella Typhimurium DT104 in different hosts. Science 341, 1514-1517 (2013).
11. Grad, Y.H. et al. Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study. Lancet Infect. Dis. 14, 220-226 (2014).
12. Croucher, N.J. et al. Rapid pneumococcal evolution in response to clinical interventions. Science 331, 430-434 (2011).
13. Sokurenko, E.V., Hasty, D.L. & Dykhuizen, D.E. Pathoadaptive mutations: gene loss and variation in bacterial pathogens. Trends Microbiol. 7, 191-195 (1999).
14. Folkesson, A. et al. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nat. Rev. Microbiol. 10, 841-851 (2012).
15. Johansen, H.K., Moskowitz, S.M., Ciofu, O., Pressler, T. & Hoiby, N. Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. J. Cyst. Fibros. 7, 391-397 (2008).
16. Wiehlmann, L. et al. Population structure of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 104, 8101-8106 (2007).
17. Jelsbak, L. et al. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect. Immun. 75, 2214-2224 (2007).
18. Zimakoff, J., Hoiby, N., Rosendal, K. & Guilbert, J.P. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic. J. Hosp. Infect. 4, 31-40 (1983).
19. Worby, C.J., Lipsitch, M. & Hanage, W.P. Within-host bacterial diversity hinders accurate reconstruction of transmission networks from genomic distance data. PLoS Comput. Biol. 10, e1003549 (2014).
20. Oliver, A., Canton, R., Campo, P., Baquero, F. & Blazquez, J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288, 1251-1254 (2000).
21. Winsor, G.L. et al. Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res. 39, D596-D600 (2011).
22. Luzar, M.A. & Montie, T.C. Avirulence and altered physiological properties of cystic fibrosis strains of Pseudomonas aeruginosa. Infect. Immun. 50, 572-576 (1985).
23. Damkiær, S., Yang, L., Molin, S. & Jelsbak, L. Evolutionary remodeling of global regulatory networks during long-term bacterial adaptation to human hosts. Proc. Natl. Acad. Sci. USA 110, 7766-7771 (2013).
24. Pai, H. et al. Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Antimicrob. Agents Chemother. 45, 480-484 (2001).
25. Ballestero, S. et al. Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patients. J. Antimicrob. Chemother. 38, 39-45 (1996).
26. Schurek, K.N. et al. Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53, 4345-4351 (2009).
27. Cabot, G. et al. Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones. Antimicrob. Agents Chemother. 56, 6349-6357 (2012).
28. Juan, C. et al. Molecular mechanisms of β-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains. Antimicrob. Agents Chemother. 49, 4733-4738 (2005).
29. Mahenthiralingam, E., Campbell, M.E. & Speert, D.P. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect. Immun. 62, 596-605 (1994).
30. Sobel, M.L., Hocquet, D., Cao, L., Plesiat, P. & Poole, K. Mutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49, 1782-1786 (2005).
31. Hancock, R.E. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative Gram-negative bacteria. Clin. Infect. Dis. 27 (suppl. 1), S93-S99 (1998).
32. Strateva, T. & Yordanov, D. Pseudomonas aeruginosa-a phenomenon of bacterial resistance. J. Med. Microbiol. 58, 1133-1148 (2009).
33. Pasca, M.R. et al. Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates. Microb. Drug Resist. 18, 23-32 (2012).
34. Huse, H.K. et al. Pseudomonas aeruginosa enhances production of a non-alginate exopolysaccharide during long-term colonization of the cystic fibrosis lung. PLoS ONE 8, e82621 (2013).
35. Kuchma, S.L. et al. BifA, a cyclic-Di-GMP phosphodiesterase, inversely regulates biofilm formation and swarming motility by Pseudomonas aeruginosa PA14. J. Bacteriol. 189, 8165-8178 (2007).
36. Davies, D.G. et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280, 295-298 (1998).
37. Choy, W.K., Zhou, L., Syn, C.K., Zhang, L.H. & Swarup, S. MorA defines a new class of regulators affecting flagellar development and biofilm formation in diverse Pseudomonas species. J. Bacteriol. 186, 7221-7228 (2004).
38. An, S., Wu, J. & Zhang, L.H. Modulation of Pseudomonas aeruginosa biofilm dispersal by a cyclic-Di-GMP phosphodiesterase with a putative hypoxia-sensing domain. Appl. Environ. Microbiol. 76, 8160-8173 (2010).
39. Goodman, A.L. et al. A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa. Dev. Cell 7, 745-754 (2004).
40. Hickman, J.W., Tifrea, D.F. & Harwood, C.S. A chemosensory system that regulates biofilm formation through modulation of cyclic diguanylate levels. Proc. Natl. Acad. Sci. USA 102, 14422-14427 (2005).
41. Behrends, V. et al. Metabolite profiling to characterize disease-related bacteria: gluconate excretion by Pseudomonas aeruginosa mutants and clinical isolates from cystic fibrosis patients. J. Biol. Chem. 288, 15098-15109 (2013).
42. Eschbach, M. et al. Long-term anaerobic survival of the opportunistic pathogen Pseudomonas aeruginosa via pyruvate fermentation. J. Bacteriol. 186, 4596-4604 (2004).
43. Aires, J.R., Kohler, T., Nikaido, H. & Plesiat, P. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 43, 2624-2628 (1999).
44. Westbrock-Wadman, S. et al. Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability. Antimicrob. Agents Chemother. 43, 2975-2983 (1999).
45. Sobel, M.L., McKay, G.A. & Poole, K. Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates. Antimicrob. Agents Chemother. 47, 3202-3207 (2003).
46. Islam, S., Jalal, S. & Wretlind, B. Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa. Clin. Microbiol. Infect. 10, 877-883 (2004).
47. Yu, H., Schurr, M.J. & Deretic, V. Functional equivalence of Escherichia coli sE and Pseudomonas aeruginosa AlgU: E. coli rpoE restores mucoidy and reduces sensitivity to reactive oxygen intermediates in algU mutants of P. aeruginosa. J. Bacteriol. 177, 3259-3268 (1995).
48. DeVries, C.A. & Ohman, D.E. Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation. J. Bacteriol. 176, 6677-6687 (1994).
49. Schurr, M.J., Martin, D.W., Mudd, M.H. & Deretic, V. Gene cluster controlling conversion to alginate-overproducing phenotype in Pseudomonas aeruginosa: functional analysis in a heterologous host and role in the instability of mucoidy. J. Bacteriol. 176, 3375-3382 (1994).
50. Ciofu, O. et al. Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants. Microbiology 154, 103-113 (2008).
51. Heeb, S. et al. Functional analysis of the post-transcriptional regulator RsmA reveals a novel RNA-binding site. J. Mol. Biol. 355, 1026-1036 (2006).
52. Yang, L. et al. In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. J. Bacteriol. 190, 2767-2776 (2008).
53. Barrick, J.E. et al. Genome evolution and adaptation in a long-term experiment with Escherichia coli. Nature 461, 1243-1247 (2009).
54. Lee, D.G. et al. Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol. 7, R90 (2006).
55. Lieberman, T.D. et al. Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures. Nat. Genet. 46, 82-87 (2014).
56. Ciofu, O., Riis, B., Pressler, T., Poulsen, H.E. & Hoiby, N. Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob. Agents Chemother. 49, 2276-2282 (2005).
57. Waine, D.J., Honeybourne, D., Smith, E.G., Whitehouse, J.L. & Dowson, C.G. Association between hypermutator phenotype, clinical variables, mucoid phenotype, and antimicrobial resistance in Pseudomonas aeruginosa. J. Clin. Microbiol. 46, 3491-3493 (2008).
58. Hoiby, N. & Frederiksen, B. in Cystic Fibrosis (eds. Hodson, M. & Geddes, D.) 83-107 (Arnold, London, 2000).
59. Zerbino, D.R. & Birney, E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 18, 821-829 (2008).
60. Kurtz, S. et al. Versatile and open software for comparing large genomes. Genome Biol. 5, R12 (2004).
61. Langmead, B. & Salzberg, S.L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357-359 (2012).
62. DePristo, M.A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491-498 (2011).
63. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
64. Swofford, D.L. PAUP. Phylogenetic Analysis Using Parsimony (and Other Methods). Version 4 (Sinauer Associates, Sunderland, MA, 2003).